**Infiltrative Lung Disease**

**Core Concept**

Infiltrative lung disease, also known as interstitial lung disease (ILD), refers to a group of disorders characterized by inflammation and fibrosis of the lung interstitium, leading to impaired gas exchange. The pathophysiology involves damage to the alveolar-capillary membrane, resulting in reduced lung volumes and impaired diffusion capacity.

**Why the Correct Answer is Right**

The correct answer is the parameter that is typically preserved or increased in infiltrative lung disease, despite the underlying lung injury. **Diffusion capacity of the lung for carbon monoxide (DLCO)** is often increased in the early stages of ILD due to the recruitment of alveolar-capillary units that are not fully involved in the disease process. However, as the disease progresses, DLCO may decrease. In contrast, lung volumes, such as total lung capacity (TLC) and vital capacity (VC), are typically decreased in ILD due to the restrictive lung disease pattern.

**Why Each Wrong Option is Incorrect**

**Option A:** Total lung capacity (TLC) is typically decreased in infiltrative lung disease due to the restrictive lung disease pattern, which is characterized by decreased lung volumes.

**Option B:** Forced expiratory volume in one second (FEV1) is also typically decreased in ILD, as the restrictive lung disease pattern impairs lung expansion and gas exchange.

**Option C:** Diffusion capacity of the lung for carbon monoxide (DLCO) is often increased in the early stages of ILD, but may decrease as the disease progresses.

**Clinical Pearl / High-Yield Fact**

In patients with ILD, a decrease in DLCO is a marker of disease progression and is associated with a poorer prognosis. Therefore, monitoring DLCO is an important part of the clinical management of these patients.

**Correct Answer:** C. Diffusion capacity of the lung for carbon monoxide (DLCO) is often increased in the early stages of ILD.